Kristen Burock
Adult Health · Canton, OHNPI 1467939371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 437 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,517 and has fallen 60.1% since, to $1,003 in 2025. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 437 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Boehringer Ingelheim$745
- Inspire Medical Systems, Inc.$495
- Regeneron Healthcare Solutions, Inc.$447
- United Therapeutics Corporation$369
- plus $3K from 32 others
What the payments were for
- Food & beverage$8,256100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 120 | $1,743 |
| AstraZeneca | 79 | $1,691 |
| Boehringer Ingelheim | 42 | $745 |
| Inspire Medical Systems, Inc. | 5 | $495 |
| Regeneron Healthcare Solutions, Inc. | 25 | $447 |
| United Therapeutics Corporation | 22 | $369 |
| Jazz Pharmaceuticals Inc. | 20 | $367 |
| Actelion Pharmaceuticals US, Inc. | 15 | $314 |
| Sanofi | 14 | $284 |
| Electromed, Inc. | 17 | $207 |
| Mylan Specialty L.p. | 8 | $179 |
| Merck | 6 | $124 |
| Amgen | 5 | $117 |
| Genentech USA, Inc. | 5 | $108 |
| Boston Scientific | 2 | $101 |
| Astellas Pharma US Inc | 4 | $90 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $86 |
| Verona Pharma, Inc. | 4 | $84 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Johnson & Johnson | 7 | $64 |
| Insmed, Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Arbor Pharmaceuticals, Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 4 | $50 |
| Grifols USA, LLC | 2 | $41 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Lundbeck LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Baxter Healthcare | 2 | $34 |
| Abbott | 1 | $25 |
| Bayer | 1 | $21 |
| EMD Serono, Inc. | 1 | $19 |
| SK Life Science, Inc. | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Resmed Corp | 1 | $16 |
| Pfizer | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Neurocrine Biosciences, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,256 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 114 | $126,768 |
| Fasenra PenBenralizumab | 12 | $68,375 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 58 | $55,276 |
| Spiriva RespimatTiotropium Bromide | 38 | $29,075 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $22,848 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 25 | $20,374 |
| SymbicortBudesonide/Formoterol Fumarate | 47 | $15,246 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 20 | $15,131 |
| Spiriva HandihalerTiotropium Bromide | 11 | $8,237 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 31 | $6,242 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 180 | $6,112 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 20 | $6,112 |
| DuleraMometasone/Formoterol | 14 | $4,878 |
| Wixela InhubFluticasone Propion/Salmeterol | 24 | $4,731 |
| Roflumilast | 42 | $3,307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $1,743 | $169,990164 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,691 | $70,523105 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $745 | $44,20558 claims |
| MerckDulera | $124 | $4,87814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Canton
- Bonnie MohlerCanton$338K
- Courtney Ray-MartyCanton$16K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Teresa ShafferBoardman$102K
- Jesse McClainYoungstown$79K
- Lucretia LongColumbus$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.